LLY
Eli Lilly and Company
NYSE · Healthcare · Drug Manufacturers - General · US
$1,145.63
−1.20%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
28.0x
EV/EBITDA
31.9x
Market Cap
$1.08T
MomentumView details →
1D Return
−1.20%
YTD Return
+7.77%
RSI (14)
42.9
ValuationView details →
P/E (Fwd)
28.0x
EV/EBITDA
31.9x
Market Cap
$1.08T
RSI (14)
42.9
MomentumView details →
1D Return
−1.20%
YTD Return
+7.77%
SummaryUpdated Jun 1, 2026
Eli Lilly and Company (NYSE:LLY) is a major American pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company has evolved from a small Indianapolis pharmacy into one of the world's largest pharmaceutical manufacturers, with a particular focus on diabetes care, oncology, immunology, and neuroscience. Lilly went public in 1972 and has established itself as a leader in innovative drug development, with recent breakthrough success in diabetes and obesity treatments that have transformed both the company's financial performance and market position in the healthcare sector.
Similar companies
Latest newsMore news →
Amplia Therapeutics entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly to evaluate narmafotinib combined with olomorasib in non-small cell lung cancer.31d agoEli Lilly and Resilience jointly invest $750 million to expand pharmaceutical manufacturing capacity in the United States.36d ago